Alzamend Neuro Stock Filter Stocks by Fundamentals
ALZN Stock | USD 1.02 0.02 2.00% |
Alzamend Neuro fundamentals help investors to digest information that contributes to Alzamend Neuro's financial success or failures. It also enables traders to predict the movement of Alzamend Stock. The fundamental analysis module provides a way to measure Alzamend Neuro's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alzamend Neuro stock.
Alzamend | Shares Owned by Insiders |
Alzamend Neuro Institutional Holders
Institutional Holdings refers to the ownership stake in Alzamend Neuro that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Alzamend Neuro's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Alzamend Neuro's value.Shares | Advisor Group Holdings, Inc. | 2023-12-31 | 66.0 | Bank Of America Corp | 2023-12-31 | 47.0 | Wells Fargo & Co | 2023-12-31 | 35.0 | Parallel Advisors, Llc | 2023-12-31 | 33.0 | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 33.0 | Bank Of New York Mellon Corp | 2023-12-31 | 0.0 | Insight Wealth Strategies, Lp | 2023-12-31 | 0.0 | Group One Trading, Lp | 2023-09-30 | 0.0 | Foundations Investment Advisors, Llc | 2023-12-31 | 0.0 | Bb&t Corp. | 2023-12-31 | 154.3 K | Vanguard Group Inc | 2023-12-31 | 78.5 K |
Alzamend Fundamentals
Return On Equity | -4.97 | ||||
Return On Asset | -1.66 | ||||
Current Valuation | 6.39 M | ||||
Shares Outstanding | 6.62 M | ||||
Shares Owned By Insiders | 28.57 % | ||||
Shares Owned By Institutions | 5.25 % | ||||
Number Of Shares Shorted | 51.22 K | ||||
Price To Book | 7.23 X | ||||
EBITDA | (14.85 M) | ||||
Net Income | (14.88 M) | ||||
Cash And Equivalents | 11.53 M | ||||
Cash Per Share | 0.12 X | ||||
Total Debt | 2.08 K | ||||
Current Ratio | 11.78 X | ||||
Book Value Per Share | (0.41) X | ||||
Cash Flow From Operations | (8.92 M) | ||||
Short Ratio | 2.25 X | ||||
Earnings Per Share | (2.28) X | ||||
Target Price | 25.0 | ||||
Beta | -0.035 | ||||
Market Capitalization | 6.75 M | ||||
Total Asset | 5.92 M | ||||
Retained Earnings | (44.07 M) | ||||
Working Capital | 2.97 M | ||||
Net Asset | 5.92 M |
About Alzamend Neuro Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alzamend Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alzamend Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alzamend Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Alzamend Neuro operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
Pair Trading with Alzamend Neuro
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alzamend Neuro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will appreciate offsetting losses from the drop in the long position's value.Moving against Alzamend Stock
0.69 | KA | Kineta Inc Report 29th of March 2024 | PairCorr |
0.62 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.47 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.46 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
The ability to find closely correlated positions to Alzamend Neuro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alzamend Neuro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alzamend Neuro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alzamend Neuro to buy it.
The correlation of Alzamend Neuro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alzamend Neuro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alzamend Neuro moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alzamend Neuro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Alzamend Neuro Piotroski F Score and Alzamend Neuro Altman Z Score analysis. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.Note that the Alzamend Neuro information on this page should be used as a complementary analysis to other Alzamend Neuro's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Alzamend Stock analysis
When running Alzamend Neuro's price analysis, check to measure Alzamend Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alzamend Neuro is operating at the current time. Most of Alzamend Neuro's value examination focuses on studying past and present price action to predict the probability of Alzamend Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alzamend Neuro's price. Additionally, you may evaluate how the addition of Alzamend Neuro to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Alzamend Neuro's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Return On Assets (1.66) | Return On Equity (4.97) |
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.